Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Curevo to support GC Pharma's vaccine development activities
May 21, 2018
By: Kristin Brooks
Managing Editor, Contract Pharma
GC Pharma, a South Korean biopharmaceutical company, has established Curevo Inc., a Seattle-based company to support GC Pharma’s vaccine development activities. GC Pharma partnered with global health organizations IDRI (Infectious Disease Research Institute) and MIBR (Mogam Institute for Biomedical Research) to form the new company. Curevo will bring together GC Pharma’s commercial scale vaccine development and understanding of protein science with IDRI and MIBR’s scientific expertise in vaccine, adjuvant and formulation development. Initial work will focus on advancing an innovative vaccine candidate against shingles to clinical stage. “Establishing Curevo signals a crucial step forward in GC Pharma’s long-standing dedication to prevent potentially serious diseases,” said EC Huh, Ph.D. president of GC Pharma. “This exciting collaboration will increase the possibilities for immune-compromised populations to have better options.” “The bottom line is that this new collaboration will take advantage of the combined strength of these three organizations to more rapidly develop infectious disease vaccines and bring them to market,” said Steve Reed, Ph.D., IDRI’s president, chief executive officer and founder. “MIBR scientists have been focusing on discovering novel cancer therapeutics and vaccines. Curevo creates an excellent conduit to achieve those goals by joining forces with GC Pharma and IDRI,” said Senyon Teddy Choe, Ph. D., MIBR’s president and director. Corey Casper, M.D., IDRI’s chief medical officer will lead the shingles project of the new company. Dr. Casper has more than 20 years of experience in designing, growing and sustaining internationally recognized programs in infection-related cancer, HIV, infection control and global oncology.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !